Immunic (IMUX) Other Operating Expenses (2014 - 2022)

Immunic has reported Other Operating Expenses for 6 years, with the latest figure at $33.0 million in Q4 2022.

• Quarterly Other Operating Expenses changed N/A year-over-year to $33.0 million in Q4 2022, while the trailing twelve-month figure through Sep 2023 was $33.0 million (changed N/A YoY) and the FY2022 annual result came in at $33.0 million, up 91.13% from the prior year.
• Other Operating Expenses advanced to $33.0 million in Q4 2022 per IMUX's latest filing, from $17.2 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $33.0 million in Q4 2022 and troughed at -$12.2 million in Q1 2018.
• A 4-year average of $4.9 million and a median of -$1.2 million in 2018 frame the typical range for Other Operating Expenses.
• The widest YoY moves for Other Operating Expenses: up 47.81% in 2019, down 47.81% in 2019.
• Over 4 years, Other Operating Expenses stood at -$1000.0 in 2018, then plunged by 636800.0% to -$6.4 million in 2019, then surged by 370.84% to $17.2 million in 2021, then surged by 91.13% to $33.0 million in 2022.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $33.0 million, $17.2 million, and -$6.4 million for Q4 2022, Q1 2021, and Q1 2019 respectively.